Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 2
2005 13
2006 7
2007 8
2008 14
2009 13
2010 18
2011 23
2012 26
2013 28
2014 26
2015 32
2016 25
2017 36
2018 38
2019 58
2020 59
2021 61
2022 53
2023 53
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. Among authors: chang p. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Reply by Authors.
Metcalf MR, Cheaib JG, Biles MJ, Patel HD, Peña VN, Chang P, Wagner AA, McKiernan JM, Pierorazio PM. Metcalf MR, et al. Among authors: chang p. J Urol. 2021 May;205(5):1293. doi: 10.1097/JU.0000000000001575.03. Epub 2021 Feb 26. J Urol. 2021. PMID: 33635089 No abstract available.
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lee NY, Ferris RL, Psyrri A, Haddad RI, Tahara M, Bourhis J, Harrington K, Chang PM, Lin JC, Razaq MA, Teixeira MM, Lövey J, Chamois J, Rueda A, Hu C, Dunn LA, Dvorkin MV, De Beukelaer S, Pavlov D, Thurm H, Cohen E. Lee NY, et al. Among authors: chang pm. Lancet Oncol. 2021 Apr;22(4):450-462. doi: 10.1016/S1470-2045(20)30737-3. Lancet Oncol. 2021. PMID: 33794205 Clinical Trial.
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
Merrill JT, Wallace DJ, Wax S, Kao A, Fraser PA, Chang P, Isenberg D; ADDRESS II Investigators. Merrill JT, et al. Among authors: chang p. Arthritis Rheumatol. 2018 Feb;70(2):266-276. doi: 10.1002/art.40360. Arthritis Rheumatol. 2018. PMID: 29073347 Free PMC article. Clinical Trial.
Birdshot Chorioretinopathy: Resistant versus Responsive.
Maleki A, Look-Why S, Manhapra A, Asgari S, Garcia CM, Al-Dabbagh A, Tsang C, Chang PY, Anesi SD, Foster CS. Maleki A, et al. Among authors: chang py. Ocul Immunol Inflamm. 2023 Apr;31(3):477-482. doi: 10.1080/09273948.2022.2032193. Epub 2022 Mar 30. Ocul Immunol Inflamm. 2023. PMID: 35353656
Editorial: The urologist's role in the opioid epidemic.
Stensland KD, Chang P, Wagner AA. Stensland KD, et al. Among authors: chang p. Curr Opin Urol. 2019 Jul;29(4):466-468. doi: 10.1097/MOU.0000000000000633. Curr Opin Urol. 2019. PMID: 31033574 No abstract available.
Late recurrence in birdshot chorioretinopathy.
Maleki A, Look-Why S, Manhapra A, Asgari S, Philip AM, Chang PY, Anesi SD, Foster CS. Maleki A, et al. Among authors: chang py. Can J Ophthalmol. 2023 Apr;58(2):77-81. doi: 10.1016/j.jcjo.2021.08.006. Epub 2021 Sep 14. Can J Ophthalmol. 2023. PMID: 34534507
534 results